Axsome Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
109.13
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
12
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.08
|
-1.07
|
0.01
|
0.93%
|
|
2022-06-30
|
-1.21
|
-1.06
|
0.15
|
12.40%
|
|
2022-03-31
|
-1.00
|
-1.03
|
-0.03
|
-3.00%
|
|
2021-12-31
|
-1.02
|
-0.90
|
0.12
|
11.76%
|
|
2021-09-30
|
-0.95
|
-0.93
|
0.02
|
2.11%
|
|
2021-06-30
|
-0.96
|
-0.86
|
0.10
|
10.42%
|
|
2021-03-31
|
-0.87
|
-0.78
|
0.09
|
10.34%
|
|
2020-12-31
|
-0.76
|
-0.78
|
-0.02
|
-2.63%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.16
|
|
2021-12-31
|
-3.47
|
|
2020-12-31
|
-2.76
|
|
2019-12-31
|
-2.00
|
|
2018-12-31
|
-1.14
|
|
2017-12-31
|
-1.29
|
|
2016-12-31
|
-1.45
|
|
2015-12-31
|
-0.12
|